NM_138773.4:c.196G>T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_138773.4(SLC25A46):c.196G>T(p.Val66Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000706 in 1,416,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. V66V) has been classified as Likely benign.
Frequency
Consequence
NM_138773.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary motor and sensory, type 6BInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- pontocerebellar hypoplasia, type 1EInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontocerebellar hypoplasia type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_138773.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC25A46 | NM_138773.4 | MANE Select | c.196G>T | p.Val66Leu | missense | Exon 1 of 8 | NP_620128.1 | ||
| SLC25A46 | NM_001303249.3 | c.196G>T | p.Val66Leu | missense | Exon 1 of 8 | NP_001290178.1 | |||
| SLC25A46 | NR_138151.2 | n.309G>T | non_coding_transcript_exon | Exon 1 of 9 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC25A46 | ENST00000355943.8 | TSL:1 MANE Select | c.196G>T | p.Val66Leu | missense | Exon 1 of 8 | ENSP00000348211.3 | ||
| SLC25A46 | ENST00000447245.6 | TSL:2 | c.196G>T | p.Val66Leu | missense | Exon 1 of 8 | ENSP00000399717.2 | ||
| SLC25A46 | ENST00000513807.5 | TSL:2 | c.-204+1068G>T | intron | N/A | ENSP00000421134.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00 AC: 0AN: 175202 AF XY: 0.00
GnomAD4 exome AF: 0.00000706 AC: 10AN: 1416874Hom.: 0 Cov.: 31 AF XY: 0.00000999 AC XY: 7AN XY: 700704 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neuropathy, hereditary motor and sensory, type 6B Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 66 of the SLC25A46 protein (p.Val66Leu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC25A46-related conditions. ClinVar contains an entry for this variant (Variation ID: 475792). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.196G>T (p.V66L) alteration is located in exon 1 (coding exon 1) of the SLC25A46 gene. This alteration results from a G to T substitution at nucleotide position 196, causing the valine (V) at amino acid position 66 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at